437 related articles for article (PubMed ID: 17964031)
21. Delayed neurotoxicity in primary central nervous system lymphoma.
Omuro AM; Ben-Porat LS; Panageas KS; Kim AK; Correa DD; Yahalom J; Deangelis LM; Abrey LE
Arch Neurol; 2005 Oct; 62(10):1595-600. PubMed ID: 16216945
[TBL] [Abstract][Full Text] [Related]
22. Primary CNS lymphoma.
Hochberg FH; Baehring JM; Hochberg EP
Nat Clin Pract Neurol; 2007 Jan; 3(1):24-35. PubMed ID: 17205072
[TBL] [Abstract][Full Text] [Related]
23. [A retrospective analysis of 8 cases with primary central nervous system lymphoma].
Zhou XQ; Liu XQ; Kong JC
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2001 Oct; 23(5):455-7. PubMed ID: 12905861
[TBL] [Abstract][Full Text] [Related]
24. Treatment options for central nervous system lymphomas in immunocompetent patients.
Jahnke K; Thiel E
Expert Rev Neurother; 2009 Oct; 9(10):1497-509. PubMed ID: 19831839
[TBL] [Abstract][Full Text] [Related]
25. Incidence, clinical features, treatment and outcome of primary central nervous system lymphoma in Norway.
Salvesen Haldorsen I; Aarseth JH; Hollender A; Larsen JL; Espeland A; Mella O
Acta Oncol; 2004; 43(6):520-9. PubMed ID: 15370608
[TBL] [Abstract][Full Text] [Related]
26. Advances in Primary Central Nervous System Lymphoma.
Patrick LB; Mohile NA
Curr Oncol Rep; 2015 Dec; 17(12):60. PubMed ID: 26475775
[TBL] [Abstract][Full Text] [Related]
27. [Primary central nervous system lymphoma: diagnosis, management and current topics].
Arita N
No To Shinkei; 2004 Mar; 56(3):195-203. PubMed ID: 15112444
[No Abstract] [Full Text] [Related]
28. Treatment approaches for primary CNS lymphomas.
Carrabba MG; Reni M; Foppoli M; Chiara A; Franzin A; Politi LS; Villa E; Ciceri F; Ferreri AJ
Expert Opin Pharmacother; 2010 Jun; 11(8):1263-76. PubMed ID: 20429667
[TBL] [Abstract][Full Text] [Related]
29. [Primary non-Hodgkin's malignant lymphoma of the central nervous system].
Monjour A; Poisson M; Kujas M; Delattre JY
Rev Neurol (Paris); 1992; 148(10):589-600. PubMed ID: 1295053
[TBL] [Abstract][Full Text] [Related]
30. Primary central nervous system lymphoma: the role of consolidation treatment after a complete response to high-dose methotrexate-based chemotherapy.
Ekenel M; Iwamoto FM; Ben-Porat LS; Panageas KS; Yahalom J; DeAngelis LM; Abrey LE
Cancer; 2008 Sep; 113(5):1025-31. PubMed ID: 18618509
[TBL] [Abstract][Full Text] [Related]
31. [The clinical analysis of primary central nervous system lymphoma in 23 patients].
Piao YZ; Li P; Liu Q; Li WL
Zhonghua Nei Ke Za Zhi; 2011 Nov; 50(11):954-7. PubMed ID: 22333130
[TBL] [Abstract][Full Text] [Related]
32. [Management of primary central nervous system lymphoma].
Gonzalez-Aguilar A; Houillier C; Soussain C; Hoang-Xuan K
Rev Neurol (Paris); 2011 Oct; 167(10):721-8. PubMed ID: 21906768
[TBL] [Abstract][Full Text] [Related]
33. [Primary central nervous system lymphoma--a single center experience].
Mitrović Z; Radman I; Aurer I; Petranović D; Santek F; Labar B
Lijec Vjesn; 2007 Dec; 129(12):391-5. PubMed ID: 18383741
[TBL] [Abstract][Full Text] [Related]
34. Pathogenesis and management of primary CNS lymphoma.
Roth P; Korfel A; Martus P; Weller M
Expert Rev Anticancer Ther; 2012 May; 12(5):623-33. PubMed ID: 22594897
[TBL] [Abstract][Full Text] [Related]
35. Primary central nervous system lymphomas: incidence and survival in the Southern and Eastern Netherlands.
van der Sanden GA; Schouten LJ; van Dijck JA; van Andel JP; van der Maazen RW; Coebergh JW;
Cancer; 2002 Mar; 94(5):1548-56. PubMed ID: 11920513
[TBL] [Abstract][Full Text] [Related]
36. Management of primary central nervous system lymphoma.
Royer-Perron L; Hoang-Xuan K
Presse Med; 2018; 47(11-12 Pt 2):e213-e244. PubMed ID: 30416008
[TBL] [Abstract][Full Text] [Related]
37. High-dose chemotherapy and autologous stem-cell transplantation without consolidating radiotherapy as first-line treatment for primary lymphoma of the central nervous system.
Illerhaus G; Müller F; Feuerhake F; Schäfer AO; Ostertag C; Finke J
Haematologica; 2008 Jan; 93(1):147-8. PubMed ID: 18166803
[TBL] [Abstract][Full Text] [Related]
38. Primary lymphoma of the central nervous system.
Singh AD; Lewis H; Schachat AP
Ophthalmol Clin North Am; 2005 Mar; 18(1):199-207, x. PubMed ID: 15763205
[TBL] [Abstract][Full Text] [Related]
39. Primary central nervous system lymphomas: salvage treatment after failure to high-dose methotrexate.
Reni M; Mazza E; Foppoli M; Ferreri AJ
Cancer Lett; 2007 Dec; 258(2):165-70. PubMed ID: 17993246
[TBL] [Abstract][Full Text] [Related]
40. Central nervous system dissemination in immunocompetent patients with aggressive lymphomas: incidence, risk factors and therapeutic options.
Ferreri AJ; Assanelli A; Crocchiolo R; Ciceri F
Hematol Oncol; 2009 Jun; 27(2):61-70. PubMed ID: 19247977
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
